GeoVax Labs, Inc. (GOVX) Form 8-K — Nov 19, 2026
GeoVax Labs disclosed that CFO Mark W. Reynolds resigned effective November 13, 2026, and that Chief Medical Officer Kelly T. McKee was terminated effective November 17, 2026. Reynolds had also served as the company's principal financial and accounting officer.
Key figures
- Termination notice days
- 90
- Interim ceo fee monthly usd
- 15000
- Cfo consulting fee monthly usd
- 10000
AI analysis
Red flags4 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.